Javier Martín-Broto Selected Research

Javier Martín-Broto Research Topics

Disease

23	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 01/2012
17	Neoplasms (Cancer) 03/2024 - 01/2012
6	Leiomyosarcoma 12/2022 - 01/2012
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2023 - 07/2015
4	Synovial Sarcoma (Synovioma) 11/2020 - 01/2012
3	Liposarcoma 12/2022 - 01/2015
2	Disease Progression 11/2023 - 09/2022
2	Giant Cell Tumor of Tendon Sheath 01/2023 - 08/2021
2	Pain (Aches) 01/2023 - 03/2005
2	Nausea 09/2022 - 10/2019
2	Fatigue 09/2022 - 10/2019
2	Adenocarcinoma 09/2020 - 01/2016
1	Rhabdomyosarcoma 01/2023
1	Pigmented Villonodular Synovitis 01/2023
1	Giant Cell Tumors (Giant Cell Tumor) 01/2023
1	Febrile Neutropenia 10/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2022
1	Solitary Fibrous Tumors 09/2022
1	Vomiting 09/2022
1	Myxoid Liposarcoma 09/2022
1	Cardiotoxicity 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 09/2020
1	Dysgeusia (Parageusia) 10/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2015
1	Necrosis 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Glioblastoma (Glioblastoma Multiforme) 12/2004

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 01/2012
9	TrabectedinIBA 09/2022 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2020
3	olaratumabIBA 03/2024 - 01/2021
3	pexidartinibIBA 01/2023 - 10/2019
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2012
3	CateninsIBA 11/2021 - 01/2017
3	Imatinib Mesylate (Gleevec)FDA Link 02/2020 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2023 - 07/2015
2	Gemcitabine FDA Link 12/2022 - 01/2018
2	Ifosfamide FDA LinkGeneric 10/2022 - 01/2015
2	AnthracyclinesIBA 01/2021 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2014
2	RG7112IBA 08/2015 - 01/2015
2	multidrug resistance-associated protein 1IBA 04/2014 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2014 - 01/2012
1	RNA (Ribonucleic Acid)IBA 03/2024
1	HMGB1 Protein (HMG1)IBA 01/2023
1	PlatinumIBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Narcotics (Narcotic Analgesics)IBA 01/2023
1	eribulin FDA Link 12/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	A-Form DNA (A-DNA)IBA 12/2021
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	LigandsIBA 01/2021
1	talimogene laherparepvecIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	ICG 001IBA 09/2020
1	olaparibIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019
1	Macrophage Colony-Stimulating FactorIBA 10/2019
1	Mitogen-Activated Protein Kinase 3IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Cytotoxins (Cytolysins)IBA 06/2017
1	TriterpenesIBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Ursolic AcidIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	maslinic acidIBA 04/2014
1	nilotinib FDA Link 01/2012
1	Therapeutic UsesIBA 01/2012
1	Estramustine FDA Link 03/2005
1	Hormones (Hormone)IBA 03/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2005
1	Temozolomide (Temodar)FDA LinkGeneric 12/2004
1	Cisplatin (Platino)FDA LinkGeneric 12/2004

Therapy/Procedure

9	Therapeutics 11/2023 - 07/2015
5	Drug Therapy (Chemotherapy) 11/2023 - 03/2005
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2022
1	Immunotherapy 11/2020
1	Neoadjuvant Therapy 01/2015
1	Aftercare (After-Treatment) 01/2015
1	Complementary Therapies (Alternative Medicine) 01/2012
1	Radiotherapy 12/2004